HemostOD
Business Services · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Rue Des Jordils Epfl Innovation Park Bât...Website
www.hemostod.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About HemostOD
HemostOD is a Swiss-based preclinical biotech company founded in 2020, focused on engineering and manufacturing universal platelets to address various medical applications. Their proprietary platform aims to treat thrombocytopenia, enable tissue-targeted cargo delivery, and promote regenerative medicine using engineered platelets. Additionally, the company collaborates with academic and industry partners to explore the culture of therapeutic stem cells. By developing an innovative and scalable manufacturing process, HemostOD provides high-quality platelets for numerous healthcare applications.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HemostOD your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at HemostOD
HemostOD, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if HemostOD had a recent Job posting/layoffs
Funding: Get notified immidiatlly once HemostOD has new funding data
Check out if HemostOD is spiking on competitors!
Product Launch: Get notified when HemostOD launches new products
Earning: See what the market has to say on HemostOD recently announced quarterly report
Check if HemostOD has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined HemostOD as Masked Content
Find more new buyers
HemostOD financials insights
Gather financial insights about HemostOD, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Seed
$5.4M
HemostOD Tech Stack
A closer look at the technologies used by HemostOD
See more technologies
HemostOD News & Media
HemostOD secures CHF 4.3 million seed extension to advance through pre-IND development and commercial scale production
Lausanne, Switzerland — 1st October 2025 – HemostOD, a private Swiss company pioneering the ex vivo manufacturing of donor-free, off-the-shelf universal human blood platelets, today announced the successful closing of a CHF 4.3 million Seed-extension financing. The round was co-led by Polytech Ventures and Orenok Holdings, with additional participation from the Lichtsteiner Foundation and other private investors.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding HemostOD
Sign Up For FreeTo access detailed company insights
HemostOD is a Swiss-based preclinical biotech company founded in 2020, focused on engineering and manufacturing universal platelets to address various medical applications. Their proprietary platform aims to treat thrombocytopenia, enable tissue-targeted cargo delivery, and promote regenerative medicine using engineered platelets. Additionally, the... Read More
